Editing Business involving high tech, life sciences and biotech

Austrianova is one company that does deals that links high tech, life sciences and biotech. It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated company that focuses in the indusion of living cells or bacteria in tiny tablets for protection which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was recognised in Singapore's greatest study biotech hub, Biopolis that has global goal in offering encapsulation choices like micro encapsulation. 

There is a speedy increasing topic of liking in healthy attention and more precise, in the matter of neutraceuticals which is the comprehension and use of probiotic bacteria. Hence, probiotics encapsulation was created. The cell-in-a-box technology was developed by Austranova with the goal to keep safe, detach, keep and transfer living cells. This protective finding can be used for numerous reasons and can be joined to probiotics, cosmetics and agriculture environmental protection and screening as well as forming the root of a powerful study gear. 

In healthcare, this technology aids run safe implantation of cells or stem cells such as cell therapy, holding them separated from the immune system and allowing long time making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure guards cells in bioreactors and fermentors and at the same time, it simplifies cleansing of bioproducts formed from the cells and it reduces production price too.

A large gauge cGMP facility for the manufacturing of biomedical grade encapsulated cell tools was beforehand effectively created and right now, Austrianova is in the journey of setting up this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to give inferior dosages of chemotherapy to be used more successfully without the usual devastating side results. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that leads to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product. 

Come to our website for additional information: <strong><b>[http://austrianova.com/ Microbeads]</b></strong>, <strong><b>[http://austrianova.com/ Cell Therapy]</b></strong>, <strong><b>[http://austrianova.com/ Cell Encapsulation Technology]</b></strong>.